• Introduction of Ebola virus into a remote border district of Sierra Leone, 2014: use of field epidemiology and RNA sequencing to describe chains of transmission.
  DeSilva M B et al. Epidemiology and infection 2019 Jan e88
• A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus.
  Flint Mike et al. Nature communications 2019 Jan 10(1) 285
• Cross-Border Transmission of Ebola Virus as the Cause of a Resurgent Outbreak in Liberia in April 2016.
  Mate Suzanne E et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2018 Sep (7) 1147-1149
• Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data.
  Soka Moses J et al. The Lancet. Global health 2016 10 (10) e736-43
• Molecular Evidence of Sexual Transmission of Ebola Virus.
  Mate Suzanne E et al. The New England journal of medicine 2015 Dec 373(25) 2448-54

more

• Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.
  Immunogenetics 2010 Dec 62 (11-12): 767-71.
  Wauquier Nadia, Padilla Cindy, Becquart Pierre, Leroy Eric, Vieillard Vince

more

• Introduction of Ebola virus into a remote border district of Sierra Leone, 2014: use of field epidemiology and RNA sequencing to describe chains of transmission.
  DeSilva M B et al. Epidemiology and infection 2019 Jan e88 DeSilva M B et al. Epidemiology and infection 2019 Jan e88
• Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study.
  Diallo Mamadou Saliou Kalifa et al. The Lancet. Infectious diseases 2019 Feb Diallo Mamadou Saliou Kalifa et al. The Lancet. Infectious diseases 2019 Feb
• Unrecognised Ebola virus infection in contact persons: what can we learn from it?
  Fletcher Tom E et al. The Lancet. Infectious diseases 2019 Feb Fletcher Tom E et al. The Lancet. Infectious diseases 2019 Feb
• Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans 1 .
  McElroy Anita K et al. Emerging infectious diseases 2019 Feb (2) 290-298 McElroy Anita K et al. Emerging infectious diseases 2019 Feb (2) 290-298
• A genome-wide CRISPR screen identifies N-acetylglucosamine-1-phosphate transferase as a potential antiviral target for Ebola virus.
  Flint Mike et al. Nature communications 2019 01 (1) 285 Flint Mike et al. Nature communications 2019 01 (1) 285

more

The Genetic Testing Registry (GTR®) provides a central location for voluntary submission of genetic test information by providers. The scope includes the test's purpose, methodology, validity, evidence of the test's usefulness, and laboratory contacts and credentials. The overarching goal of the GTR is to advance the public health and research into the genetic basis of health and disease.

• Search the Genetic Testing Registry for "Ebola"

OMIM is a comprehensive, authoritative compendium of human genes and genetic phenotypes that is freely available and updated daily.

• Search OMIM for "Ebola"

PubMed Clinical Queries is an utility offered by PubMed to search scientific literature in specific clinical research areas

• Search PubMed Clinical Queries for "Ebola"

The PharmGKB is a pharmacogenomics knowledge resource that encompasses clinical information including dosing guidelines and drug labels, potentially clinically actionable gene-drug associations and genotype-phenotype relationships.

• Search PharmGKB for "Ebola"